Since human tumors of epithelial origin often display elevated EGFR (epidermal growth factor receptor) expression, they used EGFR as a receptor target in the cancer drug delivery system and GE11 peptide as an alternative to the ligand EGF with its strongly mitogenic and neoangiogenic character [133]. Here, EGFR is linked to cancer.